Enthesis healing
US-2024390292-A1 · Nov 28, 2024 · US
Pharmaceutical compositions
US9155696B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9155696-B2 |
| Application number | US-200913058074-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2009 |
| Priority date | Aug 12, 2008 |
| Publication date | Oct 13, 2015 |
| Grant date | Oct 13, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent.
First claim
Opening claim text (preview).
The invention claimed is: 1. An injectable in situ forming depot formulation comprising i) a pharmaceutically active agent, wherein the pharmaceutically active agent is a cyclo [{4-(NH 2 —C 2 H 4 —NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe] pamoate or di-aspartate, ii) a poly (ethylene) glycol with a molecular weight 450<Mw<650Da and with alkoxy end groups which has a solidification point at a temperature between 8° to 20° C., iii) a biodegradable polymer, and optionally iv)…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K9/0024Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9155696B2 cover?
- A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent.
- Who is the assignee on this patent?
- Schönhammer Karin, Novartis Ag
- What technology area does this patent fall under?
- Primary CPC classification A61K9/0024. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).